RecruitingPhase 1 / Phase 2NCT07665021
Rare condition
Albers-Schönberg osteopetrosis
4
studies recruiting now
as of 7 Sept 2026
28
studies registered in total
as of 7 Sept 2026
2
countries with a recruiting site
as of 7 Sept 2026
24 Jun 2026
most recent study posted
among recruiting studies
Recruiting trials
RecruitingNCT03333200
Longitudinal Study of Neurodegenerative Disorders
RecruitingNCT04528355
Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC
RecruitingPhase 2NCT01962415
Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT
Showing the 4 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
Search all Albers-Schönberg osteopetrosis studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Albers-Schönberg osteopetrosis study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Albers-Schönberg osteopetrosis
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations, and the gene involved (CLCN7).
Treatments being studied
1 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Phase 2Interferon Gamma-1b (Actimmune)
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).